Erratum: Metabolic targets for cancer therapy (Nature Reviews Drug Discovery (2013) 12 (829-846))

Lorenzo Galluzzi, Oliver Kepp, Matthew G.Vander Heiden, Guido Kroemer

Résultats de recherche: Contribution à un journal › !!Comment/debate

4 Citations (Scopus)

langue originale	Anglais
Pages (de - à)	963
Nombre de pages	1
journal	Nature Reviews Drug Discovery
Volume	12
Numéro de publication	12
Les DOIs	https://doi.org/10.1038/nrd4191
état	Publié - 1 déc. 2013

Accès au document

@article{da93f009a0ad49289b9b4299aa3945fb,

title = "Erratum: Metabolic targets for cancer therapy (Nature Reviews Drug Discovery (2013) 12 (829-846))",

author = "Lorenzo Galluzzi and Oliver Kepp and Heiden, {Matthew G.Vander} and Guido Kroemer",

year = "2013",

month = dec,

day = "1",

doi = "10.1038/nrd4191",

language = "English",

volume = "12",

pages = "963",

journal = "Nature Reviews Drug Discovery",

issn = "1474-1776",

number = "12",

}

TY - JOUR

T1 - Erratum

T2 - Metabolic targets for cancer therapy (Nature Reviews Drug Discovery (2013) 12 (829-846))

AU - Galluzzi, Lorenzo

AU - Kepp, Oliver

AU - Heiden, Matthew G.Vander

AU - Kroemer, Guido

PY - 2013/12/1

Y1 - 2013/12/1

UR - http://www.scopus.com/inward/record.url?scp=84889593593&partnerID=8YFLogxK

U2 - 10.1038/nrd4191

DO - 10.1038/nrd4191

M3 - Comment/debate

AN - SCOPUS:84889593593

SN - 1474-1776

VL - 12

SP - 963

JO - Nature Reviews Drug Discovery

JF - Nature Reviews Drug Discovery

IS - 12

ER -